Matrix metalloproteinases are associated with severity of disease among COVID-19 patients: A possible pharmacological target
Description
COVID-19 is a devastating disease and imbalanced matrix metalloproteinase (MMP) activity may contribute to its pathophysiology. This exploratory study examined whether increased circulating concentrations of MMP-2 and MMP-9, and their endogenous
